Listen to this story
Why NIH support matters: A Yale M.D. explains
0:00
/
0:00
Breakthroughs in medicine start with research — and lead to better lives.
Ask Dr. Kevan Herold of Yale School of Medicine. His team’s work led to approval of the first drug able to delay the onset of Type 1 diabetes.
He’s seen firsthand the profound effects on young patients and their families.
NIH funding matters. And NIH’s announced cuts to indirect research cost reimbursements would harm everyone.
Watch this video to understand what’s at stake.
